secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001193125-25-012233
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Pharma director O'Keeffe to retire; not standing for reelection at 2025 meeting
--------------------------------------------------------------------------------

- Charles B. O'Keeffe, 85, will not stand for reelection at the 2025 annual meeting; term ends at that meeting.
- O'Keeffe has served as independent director since 2004, currently Lead Independent Director.
- Retirement not due to any disagreement with company on operations, policies, or practices.
- Corporate Governance Committee will hire a recruitment firm to search for a replacement director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312525012233/0001193125-25-012233-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312525012233/d911150d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-012233

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer